Deng J - Search Results

1

Comprehensive analysis of KCTD family genes associated with hypoxic microenvironment and immune infiltration in lung adenocarcinoma.

Shi YX, Zhang WD, Dai PH, Deng J, Tan LH. Shi YX, et al. Among authors: deng j. Sci Rep. 2022 Jun 15;12(1):9938. doi: 10.1038/s41598-022-14250-6. Sci Rep. 2022. PMID: 35705627 Free PMC article.

2

Overexpression of high mobility group protein B1 correlates with the proliferation and metastasis of lung adenocarcinoma cells.

Sun KK, Ji C, Li X, Zhang L, Deng J, Zhong N, Wu XY. Sun KK, et al. Among authors: deng j. Mol Med Rep. 2013 May;7(5):1678-82. doi: 10.3892/mmr.2013.1362. Epub 2013 Mar 6. Mol Med Rep. 2013. PMID: 23467607

3

Identifies KCTD5 as a novel cancer biomarker associated with programmed cell death and chemotherapy drug sensitivity.

Shi YX, Yan JH, Liu W, Deng J. Shi YX, et al. Among authors: deng j. BMC Cancer. 2023 May 6;23(1):408. doi: 10.1186/s12885-023-10895-2. BMC Cancer. 2023. PMID: 37149576 Free PMC article.

4

Ruscogenin induces ferroptosis in pancreatic cancer cells.

Song Z, Xiang X, Li J, Deng J, Fang Z, Zhang L, Xiong J. Song Z, et al. Among authors: deng j. Oncol Rep. 2020 Feb;43(2):516-524. doi: 10.3892/or.2019.7425. Epub 2019 Dec 10. Oncol Rep. 2020. Retraction in: Oncol Rep. 2025 Feb;53(2):30. doi: 10.3892/or.2025.8863 PMID: 31894321 Free PMC article. Retracted.

5

Follistatin-like 1 (FSTL1) is a prognostic biomarker and correlated with immune cell infiltration in gastric cancer.

Li L, Huang S, Yao Y, Chen J, Li J, Xiang X, Deng J, Xiong J. Li L, et al. Among authors: deng j. World J Surg Oncol. 2020 Dec 8;18(1):324. doi: 10.1186/s12957-020-02070-9. World J Surg Oncol. 2020. PMID: 33292276 Free PMC article.

6

Decreased INPP5B expression predicts poor prognosis in lung adenocarcinoma.

Deng J, Lin X, Li Q, Cai XY, Wu LW, Wang W, Zhang B, Li YL, Hu J, Lin NM. Deng J, et al. Cancer Cell Int. 2022 May 14;22(1):189. doi: 10.1186/s12935-022-02609-8. Cancer Cell Int. 2022. PMID: 35568951 Free PMC article.

7

Construction and validation of prognosis and treatment outcome models based on plasma membrane tension characteristics in bladder cancer.

Wang Z, Li S, Zheng F, Xiong S, Zhang L, Wan L, Wang C, Liu X, Deng J. Wang Z, et al. Among authors: deng j. PeerJ. 2025 Jan 6;13:e18816. doi: 10.7717/peerj.18816. eCollection 2025. PeerJ. 2025. PMID: 39790460 Free PMC article.

8

Stimulatory effects of sorafenib on human non‑small cell lung cancer cells in vitro by regulating MAPK/ERK activation.

Zhang YN, Wu XY, Zhong N, Deng J, Zhang L, Chen W, Li X, Zhong CJ. Zhang YN, et al. Among authors: deng j. Mol Med Rep. 2014 Jan;9(1):365-9. doi: 10.3892/mmr.2013.1782. Epub 2013 Nov 7. Mol Med Rep. 2014. PMID: 24213303

9

Bioinformatics Analysis Identified Key Molecular Changes in Bladder Cancer Development and Recurrence.

Chen Q, Hu J, Deng J, Fu B, Guo J. Chen Q, et al. Among authors: deng j. Biomed Res Int. 2019 Nov 16;2019:3917982. doi: 10.1155/2019/3917982. eCollection 2019. Biomed Res Int. 2019. PMID: 31828101 Free PMC article.

10

Increased SNX20 and PD-L1 Levels Can Predict the Clinical Response to PD-1 Inhibitors in Lung Adenocarcinoma.

Fan L, Li L, Huang C, Huang S, Deng J, Xiong J. Fan L, et al. Among authors: deng j. Onco Targets Ther. 2020 Oct 9;13:10075-10085. doi: 10.2147/OTT.S262909. eCollection 2020. Onco Targets Ther. 2020. PMID: 33116590 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11,634 results

Search Page

Filters